Literature DB >> 11710839

Analysis of the TSC1 and TSC2 genes in sporadic renal cell carcinomas.

L Parry1, J H Maynard, A Patel, S C Clifford, C Morrissey, E R Maher, J P Cheadle, J R Sampson.   

Abstract

The genetic events involved in the aetiology of non-clear-cell renal cell carcinoma (RCC) and a proportion of clear cell RCC remain to be defined. Germline mutations of the TSC1 and TSC2 genes cause tuberous sclerosis (TSC), a multi-system hamartoma syndrome that is also associated with RCC. We assessed 17 sporadic clear cell RCCs with a previously identified VHL mutation, 15 clear-cell RCCs without an identified VHL mutation and 15 non-clear-cell RCCs for loss of heterozygosity (LOH) at chromosomes 9q34 and 16p13.3, the chromosomal locations of TSC1 and TSC2. LOH was detected in 4/9, 1/11 and 3/13 cases informative at both loci. SSCP analysis of the whole coding region of the retained allele did not reveal any cases with a detectable intragenic second somatic mutation. Furthermore, RT-PCR analysis of TSC1 and TSC2 on total RNA from 8 clear-cell RCC cell lines confirmed expression of both TSC genes. These data indicate that biallelic inactivation of TSC1 or TSC2 is not frequent in sporadic RCC and suggests that the molecular mechanisms of renal carcinogenesis in TSC are likely to be distinct. Copyright 2001 Cancer Research Campaign http://www.bjcancer.com.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11710839      PMCID: PMC2375153          DOI: 10.1054/bjoc.2001.2072

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  32 in total

1.  Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background.

Authors:  H Onda; A Lueck; P W Marks; H B Warren; D J Kwiatkowski
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

2.  Allelotype of colorectal carcinomas.

Authors:  B Vogelstein; E R Fearon; S E Kern; S R Hamilton; A C Preisinger; Y Nakamura; R White
Journal:  Science       Date:  1989-04-14       Impact factor: 47.728

3.  Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas.

Authors:  T Shuin; K Kondo; S Torigoe; T Kishida; Y Kubota; M Hosaka; Y Nagashima; H Kitamura; F Latif; B Zbar
Journal:  Cancer Res       Date:  1994-06-01       Impact factor: 12.701

4.  Comprehensive allelotyping of human renal cell carcinomas using microsatellite DNA probes.

Authors:  C A Thrash-Bingham; R E Greenberg; S Howard; A Bruzel; M Bremer; A Goll; H Salazar; J J Freed; K D Tartof
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

5.  A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer.

Authors:  T Kobayashi; Y Hirayama; E Kobayashi; Y Kubo; O Hino
Journal:  Nat Genet       Date:  1995-01       Impact factor: 38.330

6.  Allelotype of pancreatic adenocarcinoma.

Authors:  A B Seymour; R H Hruban; M Redston; C Caldas; S M Powell; K W Kinzler; C J Yeo; S E Kern
Journal:  Cancer Res       Date:  1994-05-15       Impact factor: 12.701

7.  Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.

Authors:  J G Herman; F Latif; Y Weng; M I Lerman; B Zbar; S Liu; D Samid; D S Duan; J R Gnarra; W M Linehan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

8.  Identification and characterization of the tuberous sclerosis gene on chromosome 16.

Authors: 
Journal:  Cell       Date:  1993-12-31       Impact factor: 41.582

9.  Mutations of the VHL tumour suppressor gene in renal carcinoma.

Authors:  J R Gnarra; K Tory; Y Weng; L Schmidt; M H Wei; H Li; F Latif; S Liu; F Chen; F M Duh
Journal:  Nat Genet       Date:  1994-05       Impact factor: 38.330

10.  Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma.

Authors:  K Foster; A Prowse; A van den Berg; S Fleming; M M Hulsbeek; P A Crossey; F M Richards; P Cairns; N A Affara; M A Ferguson-Smith
Journal:  Hum Mol Genet       Date:  1994-12       Impact factor: 6.150

View more
  18 in total

Review 1.  Renal cancer: oxygen meets metabolism.

Authors:  Volker H Haase
Journal:  Exp Cell Res       Date:  2012-03-03       Impact factor: 3.905

2.  Tuberous sclerosis complex 2 loss of heterozygosity in patients with lung disease and cancer.

Authors:  Li Zhang; Gustavo Pacheco-Rodriguez; Wendy K Steagall; Jiro Kato; Mary Haughey; Joseph R Fontana; Vincent C Manganiello; Joel Moss
Journal:  Am J Respir Crit Care Med       Date:  2015-02-01       Impact factor: 21.405

3.  Non-invasive imaging of PI3K/Akt/mTOR signalling in cancer.

Authors:  Snehal M Gaikwad; Pritha Ray
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-10-15

4.  Novel mechanism of regulation of the DNA repair enzyme OGG1 in tuberin-deficient cells.

Authors:  Samy L Habib; Besant K Bhandari; Nahed Sadek; Sherry L Abboud-Werner; Hanna E Abboud
Journal:  Carcinogenesis       Date:  2010-09-13       Impact factor: 4.944

5.  Interplay between pVHL and mTORC1 pathways in clear-cell renal cell carcinoma.

Authors:  Blanka Kucejova; Samuel Peña-Llopis; Toshinari Yamasaki; Sharanya Sivanand; Tram Anh T Tran; Shane Alexander; Nicholas C Wolff; Yair Lotan; Xian-Jin Xie; Wareef Kabbani; Payal Kapur; James Brugarolas
Journal:  Mol Cancer Res       Date:  2011-07-28       Impact factor: 5.852

Review 6.  Tuberous sclerosis complex: the past and the future.

Authors:  Liesbeth De Waele; Lieven Lagae; Djalila Mekahli
Journal:  Pediatr Nephrol       Date:  2014-12-23       Impact factor: 3.714

Review 7.  Tuberous sclerosis complex: a brave new world?

Authors:  Kevin C Ess
Journal:  Curr Opin Neurol       Date:  2010-04       Impact factor: 5.710

8.  Evidence for aldosterone-dependent growth of renal cell carcinoma.

Authors:  Sharon King; Susan Bray; Sarah Galbraith; Lesley Christie; Stewart Fleming
Journal:  Int J Exp Pathol       Date:  2014-05-07       Impact factor: 1.925

Review 9.  Growth controls connect: interactions between c-myc and the tuberous sclerosis complex-mTOR pathway.

Authors:  Emmett V Schmidt; Michael J Ravitz; Li Chen; Mary Lynch
Journal:  Cell Cycle       Date:  2009-05-18       Impact factor: 4.534

10.  Insight into mechanism of oxidative DNA damage in angiomyolipomas from TSC patients.

Authors:  Samy L Habib
Journal:  Mol Cancer       Date:  2009-03-05       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.